TR Duo Tablet 80/10 mg
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Binex Co., Ltd.
MFDS item code 201906979 · Approved 2019.09.30
This product's status changed to Approval withdrawn on 2024.08.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
This medication is used for patients who need to administer telmisartan and rosuvastatin together. Telmisartan helps primarily in the treatment of essential hypertension and reduces the risk of cardiovascular disease. It is particularly effective in reducing the risk of myocardial infarction, stroke, and death related to cardiovascular disease in high-risk patients. Rosuvastatin primarily controls hypercholesterolemia and various dyslipidemias, lowering blood cholesterol and LDL levels, and delaying the progression of atherosclerosis. Furthermore, it reduces the risk of cardiovascular disease and the risk associated with stroke, myocardial infarction, and vascular revascularization. Therefore, this medication is used to improve the cardiovascular health of patients with both hypertension and hyperlipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan/rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after treatment is started. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be necessary. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience of administration.
This medication may cause serious harm or death to the fetus and newborn, particularly during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are allergic to this medication or its ingredients, pregnant or possibly pregnant, or nursing should not take it. Patients with severe hepatic impairment or biliary obstruction should not take this medication. Patients with muscle disease or hereditary angioedema, severe renal failure, or those taking certain medications should also refrain from taking this medication. Elderly patients, those with hyperkalemia, and patients with mild hepatic impairment should be careful while taking this medication, and regular monitoring is necessary as liver and muscle issues may arise. This medication may cause muscle-related side effects, such as myalgia, myopathy, and rhabdomyolysis. Consult your physician immediately if experiencing symptoms like myalgia or weakness. Be cautious as blood pressure may drop too low, causing dizziness, fainting, etc., and closely monitor symptoms during use. This medication may cause liver dysfunction, so liver enzyme levels should be checked regularly, and discontinuation is necessary if abnormalities are found. Since it can interact with other medications, inform your doctor or pharmacist of any concurrent medications you're taking. Women who are pregnant or nursing should not take this medication, and women planning to become pregnant should use appropriate contraception. Safety and efficacy in children have not been established, hence its use is not recommended. In case of overdose, symptoms like hypotension, dizziness, and abnormal heart rate may occur, requiring immediate medical attention and treatment. During the use of this medication, drowsiness or dizziness may occur when driving or operating machinery, so caution is advised.
Headache, positional dizziness, sleep paralysis, increased blood pressure, decreased blood pressure, hypotension, increased ALT, dysuria, rhinitis, discomfort in the oropharynx, lung disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, decreased sensation, movement disorders, atherosclerosis, increased urinary frequency, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, lumbago, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, increased serum CK, decreased hemoglobin, decreased libido, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, weakness, edema, facial edema, alopecia, conjunctivitis, noise in the ear, petechiae, constipation, nausea, pancreatitis, pruritus, myopathy, rhabdomyolysis, numbness, chest discomfort, syncope, widespread pain, muscle cramps, gout, headache, facial edema, rash, alopecia, conjunctivitis, noise in the ear, petechiae, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory impairment, forgetfulness, amnesia, memory disorders, confusion, severe muscle weakness, ocular myasthenia, hypotension, tachycardia, bradycardia, dizziness, acute renal failure, shock, loss of consciousness, liver dysfunction, jaundice, anaphylactoid symptoms, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, lack of effectiveness, cough, dyspepsia, chest pain, myalgia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal bloating, pruritus, abnormal liver function tests, syncope, widespread pain, muscle cramps, gout, erectile dysfunction, joint pain, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication is prone to damage from air and moisture, so it must be stored in a sealed container. Additionally, avoid extremely cold or hot places, and store at a safe temperature between 1°C and 30°C.
Bright blue oval film-coated tablet
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Binex Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.